- Home
- TKLF vs CODX Comparison
TKLF vs CODX Comparison
Compare TKLF & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- CODX
- Stock Information
- Founded
- TKLF 2006
- CODX 2013
- Country
- TKLF Japan
- CODX United States
- Employees
- TKLF N/A
- CODX N/A
- Industry
- TKLF Other Specialty Stores
- CODX Medical/Dental Instruments
- Sector
- TKLF Consumer Discretionary
- CODX Health Care
- Exchange
- TKLF Nasdaq
- CODX Nasdaq
- Market Cap
- TKLF 13.3M
- CODX 11.9M
- IPO Year
- TKLF 2022
- CODX 2017
- Fundamental
- Price
- TKLF $4.03
- CODX $0.34
- Analyst Decision
- TKLF
- CODX Buy
- Analyst Count
- TKLF 0
- CODX 2
- Target Price
- TKLF N/A
- CODX $5.50
- AVG Volume (30 Days)
- TKLF 42.3K
- CODX 254.3K
- Earning Date
- TKLF 12-18-2024
- CODX 05-08-2025
- Dividend Yield
- TKLF N/A
- CODX N/A
- EPS Growth
- TKLF N/A
- CODX N/A
- EPS
- TKLF 1.70
- CODX N/A
- Revenue
- TKLF $219,520,631.00
- CODX $3,497,583.00
- Revenue This Year
- TKLF N/A
- CODX N/A
- Revenue Next Year
- TKLF N/A
- CODX N/A
- P/E Ratio
- TKLF $2.37
- CODX N/A
- Revenue Growth
- TKLF 32.02
- CODX N/A
- 52 Week Low
- TKLF $2.00
- CODX $0.28
- 52 Week High
- TKLF $8.53
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- TKLF 76.81
- CODX 44.01
- Support Level
- TKLF $3.71
- CODX $0.32
- Resistance Level
- TKLF $3.90
- CODX $0.50
- Average True Range (ATR)
- TKLF 0.30
- CODX 0.04
- MACD
- TKLF 0.07
- CODX 0.00
- Stochastic Oscillator
- TKLF 88.05
- CODX 13.61
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.